PDG17 Adverse Drug Reactions Associated to Hydroxychloroquine and Remdesivir in COVID-19 Patients: Analysis of Reported ADR to the Portuguese Pharmacovigilance System
Jun 1, 2021, 00:00
10.1016/j.jval.2021.04.465
https://www.valueinhealthjournal.com/article/S1098-3015(21)00682-3/fulltext
Title :
PDG17 Adverse Drug Reactions Associated to Hydroxychloroquine and Remdesivir in COVID-19 Patients: Analysis of Reported ADR to the Portuguese Pharmacovigilance System
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)00682-3&doi=10.1016/j.jval.2021.04.465
First page :
Section Title :
Open access? :
No
Section Order :
11025